Targeted Colorectal Cancer Combo Improves QoL Targeted Colorectal Cancer Combo Improves QoL

Patients with metastatic colorectal cancer who have the KRAS G12C mutation demonstrated improved quality of life following sotorasib and panitumumab compared with standard therapy.MDedge News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology Source Type: news